Applewood, Colorado Nov 5, 2021 (Issuewire.com) - Market Overview
Hepatitis A Vaccine is a vaccine that prevents hepatitis A. The disease is a liver disorder caused by the hepatitis A virus leading from mild to severe illness. The Hepatitis A Virus (HAV) is transferred through either ingestion of contaminated food and water or direct contact with an infectious person.
The disease has a propensity for cyclic reappearances, which occur in epidemics globally. The Antibodies introduced in response to the disease lasts through life and protect against recurrence of infection, the best way for which is through vaccination. It is given in two doses injected six months apart.
View full report: https://bit.ly/3q6yvsb
Market Dynamics
The major factors propelling the growth of the Hepatitis A Vaccine market are the increasing prevalence of hepatitis A globally, which leads to increasing concerns for vaccination. The rise in the number of Hepatitis A cases propels the national governments and healthcare organizations to introduce steps to increase awareness about the disease and manage vaccination drives in the risk-prone areas. Further continuous efforts by the market players to promote Hepatitis A vaccines drive the market growth.
Increasing Government Initiatives for Prevention
Hepatitis A Vaccine is used to submerge the rising cases of Hepatitis A. As per the Center for Disease Control, in 2018, the U.S. reported a total of 12,474 hepatitis A cases, and the organization estimated the actual number of cases reported in the year to be 24,900 owing to the undiagnosed cases. This has propelled governments to increase their efforts for awareness, diagnosis, treatment, and vaccination. As per the World Health Organization, as of May 2019, the introduction of the Hepatitis A vaccine in routine immunization of children in specific risk groups was used or planed by a total of 34 countries across the globe. According to the WHO, approximately 90.0% of children are infected with the hepatitis A virus before 10 years in developed countries with inadequate sanitary conditions and sanitation habits. Government vaccination programs are propelling the worldwide market for hepatitis A vaccines in developing countries.
Segmentation Analysis:
By Product Type
- Inactivated vaccine
- Live Attenuated Vaccine
By Application
- Government Institution
- Private Sector
Download free sample: https://bit.ly/3BLiav9
Geographical Analysis
Based on geography, the study analyzes the Hepatitis A Vaccine market globally, including North America, Europe, Asia-Pacific, South America, and the Middle East & Africa.
Asia-Pacific is expected to dominate the global Hepatitis A Vaccine market.
Asia-Pacific held a dominant position in the global Hepatitis A Vaccine market in 2019. In Asia-Pacific, China is expected to represent considerable growth during the forecast period. As in China, the live attenuated Hepatitis A Vaccine is becoming a favorable element to tackle the disease. Moreover, Europe is expected to represent significant growth in terms of value during the forecast period. The easy availability of vaccines at a comparatively lower cost is expected to propel market growth across the region. The Hepatitis A Vaccine market for the Asia Pacific is expected to observe rapid growth over the forecast period, backed by government policies and programs, especially in India and China. Moreover, the rise in the pediatric population and increased awareness about vaccination results in increasing demand for Hepatitis A Vaccine in emerging economies, such as India and China, which is expected to augment Asia Pacific's growth Hepatitis A Vaccine market.
Competitive Landscape
The Hepatitis A Vaccine market is highly competitive, owing to the presence of major market players. The key Hepatitis A Vaccine players contributing to the global market's growth include GlaxoSmithKline, Merck & Co. Inc., Sanofi, Sinovac, Zhejiang Pukang, Changchun Institute of Biological, KM Biologics, IMBCA, ChangSheng, Convac, among others. The major players are adopting new expansion strategies for global growth in the Hepatitis A Vaccine market.
Trending Topics:
Age Related Vaccine Adjuvant Market, Live Attenuated Vaccines Market, Preventive Vaccine Market
Media Contact
DataM Intelligence info@datamintelligence.com +18774414866 India https://www.datamintelligence.com/
